Based on recent data, NovaBridge Biosciences (NBP) shows an Average True Range (ATR) of 0.24 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 858.62K, indicating liquidity. These fundamental metrics provide insight into NBP's underlying financial health and market activity.
| ATR | 0.24 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 858.62K |
| Avg Vol (10 Days) | 264.9K |
NovaBridge Biosciences (NBP) technical indicators as of June 27, 2026: the SMA 20 is -2.41%, SMA 50 at -12.4%, and SMA 200 at -6.09%. The RSI 14 value is 41.77, suggesting its current momentum. These technical analysis signals help assess NBP's price trends and potential future movements.
| SMA 20 | -2.41% |
| SMA 50 | -12.4% |
| SMA 200 | -6.09% |
| RSI 14 | 41.77 |
NovaBridge Biosciences (NBP) stock performance overview as of June 27, 2026: The 52-week high is $5.19 (currently -51.69% below), and the 52-week low is $1.46 (currently 451.26% above). Over the past year, NBP's performance is 256.36%, compared to the S&P 500's 7.55% change.
| 52-Week High | 5.19 |
| 52-Week High Chg | -51.69% |
| 52-Week Low | 1.46 |
| 52-Week Low Chg | +451.26% |
| S&P 500 52-Week Chg | 7.55% |
According to market data, NovaBridge Biosciences (NBP) stock's recent performance metrics show that over the last month, NBP is -5.08%, with a Year-to-Date (YTD) performance of -1.51%. Over the past year, the stock has seen a 256.36% change. These figures summarize NBP's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 1.66 | 1.93 | 2.78 | 5.19 | 5.19 | 5.19 |
| Low | 1.47 | 1.46 | 1.46 | 1.46 | 1.46 | 1.46 |
| Performance | +5.38% | -5.08% | -32.06% | +84.91% | +256.36% | -1.51% |
According to current financial data, NBP stock's P/E (TTM) ratio is -18.93, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.21. Key valuation ratios for NBP, including P/S (N/A), P/B (16.92), and P/FCF (-885.78), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | NBP | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -18.93 | -1.21 | -193.77 | 32.59 |
| P/S (TTM) | N/A | 3.68 | 466.48 | 5.98 |
| P/B (TTM) | 16.92 | 0.43 | 11.15 | 5.4 |
| P/FCF (TTM) | -885.78 | -13.31 | -975.27 | 30.58 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep